Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 27 August 2009, Vol. 114, No. 9, pp. 1958-1967.
Prepublished online as a Blood First Edition Paper on May 14, 2009; DOI 10.1182/blood-2009-03-213256.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2009-03-213256v1
114/9/1958    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Hanley, P. J.
Right arrow Articles by Bollard, C. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanley, P. J.
Right arrow Articles by Bollard, C. M.
Related Collections
Right arrow Transplantation
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

TRANSPLANTATION

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

Patrick J. Hanley1,2, Conrad Russell Young Cruz1, Barbara Savoldo1,3, Ann M. Leen1,3, Maja Stanojevic1, Mariam Khalil1, William Decker4, Jeffrey J. Molldrem4, Hao Liu1,5, Adrian P. Gee1,3, Cliona M. Rooney1,3,6, Helen E. Heslop13, Gianpietro Dotti1,2,5, Malcolm K. Brenner13, Elizabeth J. Shpall4, and Catherine M. Bollard13,5

1 Center for Cell and Gene Therapy and Departments of 2 Immunology and 3 Pediatrics, Baylor College of Medicine, Texas Children's Hospital and The Methodist Hospital, Houston; 4 Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston; and Departments of 5 Medicine and 6 Virology, Baylor College of Medicine, Texas Children's Hospital and The Methodist Hospital, Houston

The naive phenotype of cord blood (CB) T cells may reduce graft-versus-host disease after umbilical cord blood transplantation, but this naivety and their low absolute numbers also delays immune reconstitution, producing higher infection-related mortality that is predominantly related to CMV, adenovirus (Adv), and EBV. Adoptive immunotherapy with peripheral blood-derived virus-specific cytotoxic T lymphocytes (CTLs) can effectively prevent viral disease after conventional stem cell transplantation, and we now describe the generation of single cultures of CTLs from CB that are specific for multiple viruses. Using EBV-infected B cells transduced with a clinical-grade Ad5f35CMVpp65 adenoviral vector as sources of EBV, Adv, and CMV antigens, we expanded virus-specific T cells even from CB T cells with a naive phenotype. After expansion, each CTL culture contained both CD8+ and CD4+ T-cell subsets, predominantly of effector memory phenotype. Each CTL culture also had HLA-restricted virus-specific cytotoxic effector function against EBV, CMV, and Adv targets. The CB CTLs recognized multiple viral epitopes, including CD4-restricted Adv-hexon epitopes and immunosubdominant CD4- and CD8-restricted CMVpp65 epitopes. Notwithstanding their naive phenotype, it is therefore possible to generate trivirus-specific CTLs in a single culture of CB, which may be of value to prevent or treat viral disease in CB transplant recipients. This study is registered at www.clinicaltrials.gov as NCT00078533 [ClinicalTrials.gov] .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Expanding multiviral reactive T cells from cord blood
Richard W. Childs and Christa S. Zerbe
Blood 2009 114: 1725-1726. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. S. Hinrichs, Z. A. Borman, L. Cassard, L. Gattinoni, R. Spolski, Z. Yu, L. Sanchez-Perez, P. Muranski, S. J. Kern, C. Logun, et al.
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
PNAS, October 13, 2009; 106(41): 17469 - 17474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. W. Childs and C. S. Zerbe
Expanding multiviral reactive T cells from cord blood
Blood, August 27, 2009; 114(9): 1725 - 1726.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020